CMS finalizes competitive bidding changes to diabetes devices
AdvaMed supported changes made from a draft version but still has concerns about the impact on patient access.
CMS finalizes competitive bidding changes to diabetes devices Read More »
Uncategorized
UK Agrees To Boost Drug Spending by 25% To Avoid US Pharma Tariffs
U.K.-based pharmas will not face tariffs as long as Donald Trump is president, according to the agreement.
UK Agrees To Boost Drug Spending by 25% To Avoid US Pharma Tariffs Read More »
Nuevas innovaciones en fregonas eléctricas y su impacto en la eficiencia del hogar
El orden, las tareas de la casa y la limpieza del hogar influyen en el cuidado de la vivienda y en el bienestar personal. La innovación en el diseño de dispositivos con nuevas funcionalidades simplifica la realización de tareas cotidianas como, por ejemplo, limpiar el …
Nuevas innovaciones en fregonas eléctricas y su impacto en la eficiencia del hogar Read More »
Humana appeals Medicare Advantage star ratings loss to 5th Circuit
The insurer continues to try to prove that regulators acted arbitrarily in downgrading its quality scores for 2025, despite numerous setbacks in the courts to date.
Humana appeals Medicare Advantage star ratings loss to 5th Circuit Read More »
J&J’s US orthopedic leader leaves amid DePuy spinout process
Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.
J&J’s US orthopedic leader leaves amid DePuy spinout process Read More »
Lilly Cuts Zepbound Prices, Again, When Buying Through DTC Program
Following Novo Nordisk’s price cuts for its own GLP-1 medicines, Eli Lilly is offering discounts for the obesity drug purchased through LillyDirect. Both pharmas recently struck a deal with the White House for cheaper prices via the yet-to-be-launched TrumpRx.
Lilly Cuts Zepbound Prices, Again, When Buying Through DTC Program Read More »
Building a better robot: How Virtual Incision plans to challenge Intuitive
Led by former Intuitive executive Jim Alecxih, Virtual Incision expects the miniaturized design of its robot to stand out in an increasingly crowded field of challengers.
Building a better robot: How Virtual Incision plans to challenge Intuitive Read More »
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B
Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the underlying biological cause of AL amyloidosis.
Novartis-Backed Protego Eyes Pivotal Amyloidosis Study With $130M Series B Read More »
FDA Delays Decision on Ascendis’ Dwarfism Drug By Three Months
If approved, Ascendis’ TransCon CNP would become the second therapy for achondroplasia, challenging BioMarin’s Voxzogo.
FDA Delays Decision on Ascendis’ Dwarfism Drug By Three Months Read More »
FDA’s Prasad Links 10 Child Deaths to COVID-19 Vaccines, Eyes Stricter Review Guidelines
The alleged deaths were detected by the FDA’s Vaccine Adverse Event Reporting System, reports from which “generally cannot be used to determine” causation or even contribution, according to the agency.
FDA’s Prasad Links 10 Child Deaths to COVID-19 Vaccines, Eyes Stricter Review Guidelines Read More »